Investors and innovators converge in Hong Kong for major healthcare events.

Fuelling global healthcare collaboration

Insilico Medicine has developed a pioneering AI-discovered clinical medicine.

Hong Kong’s AI moment

Supernova Academy revolutionises medical training through its regional base in Hong Kong.

Medtech start-up leverages city’s innovation ecosystem

Conferences and fairs support new initiatives for the elderly.

Silver economy promises golden opportunities

13,000 buyers flock to Asia’s premier healthcare and medical sourcing fair.

Summit strives for healthy, inclusive future

The Hong Kong Polytechnic University and Nanjing Hanwei Public Health Research Institute have developed an AI early warning platform to more effectively prevent and treat respiratory infectious diseases.

Hong Kong and Nanjing researchers cooperate to develop early warning platform for respiratory diseases.

AI raises disease alert

Hong Kong is quickly developing into one of the world’s leading innovation hubs, with healthtech and biotech at the forefront.

Hong Kong reforms regulatory approach to fast track drug and medical device development.

Healthtech innovation accelerates

The Hong Kong Polytechnic University has been at the forefront of addressing myopia, an eye disorder that affects one-third of the global population, with a novel non-invasive solution to control the development of myopia in children.

PolyU teams up with leading German lens maker ZEISS to accelerate market penetration of patented myopia control technology.

Farsighted deal to counter myopia

Generating bespoke bone components – anything from a skull plate to part of a load-bearing arm bone – on a 3D printer might seem far-fetched, but that is just what Hong Kong biomaterials pioneer NOVUS Life Sciences does.

A Hong Kong biotech firm established solid overseas connections through HKTDC’s pavilion at a leading German fair.

Bone-builder expands abroad

In the 1970s, Hong Kong was a manufacturing powerhouse churning out everything from toy trains to microchips. Over the 1980s and 90s, the factories migrated north into Mainland China.

Programmes lead the way to bring ‘Made in Hong Kong’ back into the sunshine.

Smart technology revives industry

Hong Kong start-up Neuropix has developed a portable wireless electronic medical device that uses electronic pulses as non-surgical treatment for brain disorders, stimulating cranial nerves and relieving symptoms of cranial nerve diseases.

A Hong Kong entrepreneur is feted for developing a non-invasive electronic-pulse treatment for cranial disorders.

Start-up generates brain waves

The Hong Kong Trade Development Council (HKTDC) helped the Chinese University of Hong Kong (CUHK) reach a research agreement with AI Medical Service (AIM) – a Japanese medical start-up which develops artificial intelligence (AI) endoscopic diagnostic technology – to accelerate development, promote it in Hong Kong and enhance clinical application in other Asian economies.

CUHK and Japanese AI start-up tackle problem of late-diagnosis for alimentary tumours.

AI takes digestive cancers to task

Interest in healthcare and medical developments continues to grow, as economies worldwide recover from the COVID-19 crisis. Market leaders and industry players again congregated at the HKTDC Hong Kong International Medical and Healthcare Fair showcasing medical trends and innovations. Now in its 13th edition, the fair continued to draw an international crowd, including representatives from the Consulates General of Canada, Czech Republic, Israel, and the United States. The physical-online hybrid format, in which the event was conducted, encouraged both on-site and online interactions.

Leading medical industry players reaffirm Hong Kong’s role as a gateway to the massive Mainland China market.

GBA grows into healthcare hub

Hong Kong earlier this month hosted its second Asia Summit on Global Health (ASGH), as the city continues to garner international attention after further loosening COVID-19 restrictions. This year’s theme – “Charting a New Course in Healthcare through Collaboration” resonated strongly with Dr Zsuzsanna Jakab (main picture), Deputy Director-General of the World Health Organization. In her video speech at the event’s opening session, Dr Jakab said the pandemic had infected more than 600 million people globally and claimed 6.5 million lives, so there was an “opportunity and, indeed, an obligation to learn from this pandemic” and accelerate progress on universal healthcare through concerted efforts in science, research, innovation, data and digital technologies.

Diverse range of centres in the Greater Bay Area offer a glimpse into the region’s vibrant healthcare market.

Health summit boosts medical hub credentials

Partnership with Mainland hospital holds potential for clinical applications.

Summit connection opens new path for neuroscience drug developer

Learn about latest market updates and insights to empower your business.

Subscribe to our free e-newsletter

Dr Hou Yunlong of Yiling Pharmaceutical talks to the HKTDC at the Asia Summit on Global Health (ASGH). Organised by the Hong Kong Trade Development Council (HKTDC), the fifth ASGH was held on 26-27 May 2025 at the Hong Kong Convention and Exhibition Centre. Under the theme Fostering Global Collaboration for a Shared Future, the summit brings together more than 80 healthcare leaders and experts from around the world to explore the future direction of the industry and collaboration opportunities.

Medicine